Lustro Comments

Discuss this Deal with other Investors

Psyonic

Redefining Human

Print
Claim My Business
Security Type
Common Stock
Categories
Technology, Industrial, Healthcare & Medical
Min Investment
$249
Location
SAN DIEGO, CA
Offering Date
October 24, 2022
Expected Close Date
April 29, 2024
Target Raise
$10.00K-$2.74M
No. Investors
1451
Security Price
$2.43
Valuation
$49,937,500
Website
psyonic.io
Number of Employees
21
Cash
$438,919
Revenue
$1,655,166
Short Term Debt
$21,384
Cost of Goods
$810,759
Long Term Debt
$1,615,902
Net Income
$75,758

Company Description

PSYONIC’s Ability Hand offers those with limb differences the high-performance solution they deserve. It has designed the bionic hand to be the fastest and believes that it is the first of its kind to offer true multi-touch sensitivity. Prioritizing affordability, PSYONIC has worked diligently to ensure that the products cost less and are covered by Medicare as well as private insurance.

The idea is revolutionary. The product is changing the lives of people by giving them an active prosthetic hand that can help them feel and hold things like a normal hand does. 

Goldman Sachs estimates that the robotics industry market will grow to $6B by 2035. The global market for prosthetics and orthotics is approaching the $2.8B mark and has the potential to expand as a population of about 3.5M people are estimated to potentially experience limb loss by 2050
The top 3 competitors making multi-articulated hands are TASKA by Taska Prosthetics, i-Limb by Ossur, and bebionic by OttoBock. The company believes its product is 2.5x faster, 25% lighter, and more robust. Also, its competitors' produced hands do not provide sensory feedback to users. Robotics researchers globally have been purchasing the Ability Hand, including Meta (Facebook), Apptronik, Sanctuary AI, and NASA for robotics research. The product is priced at $12k

The company currently has four patents, 2 granted and 2 pending. 

Revenue in 2022 was $1.66M, 2.5x the revenue in 2021. The gross margin is 51% and the net margin is 4.5%, implying the company is already profitable.

Perks

Select this bonus $249+ Investment StartEngine Owner’s Bonus This offering is eligible for the StartEngine Owner’s 10% Bonus program. For details on this program, please see the Offering Summary section below. Select this bonus Super Early Bird Bonus Invest within the first two weeks and receive 5% bonus shares 13 days 10 hours 56 mins 20 secs Select this bonus $500+ Investment Tier 1 Invest $500+ and Join the Owner’s Group, which includes exclusive access to investor updates, webinars, and PSYONIC merch Select this bonus $1,500+ Investment Tier 2 Invest $1,500+ and Receive 2% Bonus Shares + Join the Owner’s Group Select this bonus $2,500+ Investment Tier 3 Invest $2,500+ and Receive 3% Bonus Shares + Joint the Owner’s Group Select this bonus $5,000+ Investment Tier 4 Invest $5,000+ and Receive 5% Bonus Shares + Join the Owner’s Group Select this bonus $10,000+ Investment Tier 5 Invest $10,000+ and Receive 10% Bonus Shares + 30-minute call with CEO/Founder Aadeel Akhtar + Join the Owner’s Group Select this bonus $20,000+ Investment Tier 6 Invest $20,000+ and Receive 20% Bonus Shares + 30-minute call with CEO/Founder Aadeel Akhtar + Join the Owner’s Group

Key Deal Facts

PSYONIC’s Ability Hand™ offers those with limb differences the high-performance solution they deserve. We designed our bionic hand to be the fastest, and believe that it is the first of its kind to offer true multi-touch sensitivity (source). For what we believe is the very first time with a commercially available bionic hand, users can feel a vibration from multiple areas of the fingers when they touch an object! The global market for prosthetics and orthotics is approaching the $2.8 billion mark and has the potential to expand as a population of about 3.5 million people are estimated to potentially experience limb loss by 2050 (source). Prioritizing affordability, PSYONIC has worked diligently to ensure that our products cost less (source) and are covered by Medicare as well as private insurance (source).

Use of Proceeds

The company plans to use the proceeds for R&D, marketing, manufacturing, operations, sales and support, and platform fees.

Management Team / Advisory Board Bios

Dr. Aadeel Akhtar, CEO & Founder
Dr. Aadeel Akhtar is all in on creating a bionic revolution. The revolution is going to deliver the best prosthetic devices at an affordable price and ensure that the robots of the future can work well in environments that are designed for humans. He founded PSYONIC while in graduate school and left medical school to make sure that the company would thrive. Aadeel was named one of MIT Technology Review’s top 35 Innovators Under 35 and America’s Top 50 Disruptors in Newsweek in 2021. He earned a BS in biology and an MS in computer science from Loyola University Chicago and an MS in electrical and computer engineering and a PhD in neuroscience from the University of Illinois Urbana-Champaign. He is a first-time founder and works full-time with Psyonic. 

The company has a strong technical management team.

Valuation Notes

The company has valued itself at $50M pre-money. It has contemplated additional future sources of capital including at least $1m in grant funding from the National Science Foundation and other organizations. The company has raised previous funds by issuing SAFE as a liability. While the product is truly revolutionary and the company is profitable, a little more traction and scalability would be required to justify the valuation.

Amount Raised : $2,257,654
Reveal the Score by Voting
_
Additional ratings from other users are needed to determine a viable CrowdScore for this deal.
The "CrowdScore" for this deal is determined by user ratings and other factors using our proprietary algorithm.
The overall viability and scalability of the business concept as well as the ability to drive the concept to profitability over time.
Business Idea
The progress made thus far in demonstrating that the business has viability, a customer base or other business traction.
Business Traction
The experience of the management team in running, scaling and/or exiting a business that required similar skills to execute the business plan.
Management Team
The value of the company compared to similar companies raising money from investors.
Valuation

Security Description

Common stock is a security that represents ownership in a corporation.

Research Reports

No reports have been submitted

Become a Reporter

0 Comments